Por: The New York Times Health January 14, 2023
Fears that the Covid booster shots made by Pfizer-BioNTech may increase the risk of strokes in people aged 65 and older were not borne out by an intensive scientific investigation, federal officials said on Friday.“It is very unlikely” that the risk is real, the officials said. They urged Americans 6 months and older to continue getting booster shots. Federal officials decided to disclose the concern and the results of their investigation... + full article
CNBC USA Health January 14, 2023
A patient receives a Covid-19 vaccine booster shot at a Pfizer-BioNTech vaccination clinic in Southfield, Michigan, on Sept. 29, 2021.Emily Elconin ReutersThe Centers for Disease Control and Prevention on Friday said it is very unlikely the Pfizer omicron booster carries a risk... + más
Moderna vs Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | Los Angeles Times
Moderna vs. Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | PennLive
Ars Technica USA Science December 14, 2022
Navigate Filter by topic Settings Front page layout Site theme - Dec 14, 2022 1:57 pm UTC / Pfizer Chairman and CEO Dr. Albert Bourla speaks onstage at the 2022 SXSW Conference at JW Marriott Austin on March 14, 2022, in Austin. Share this story Senator Elizabeth Warren... + más
Pfizer rejects Moderna claim it copied Covid vaccine, accuses rival of rewriting history | CNBC
Pfizer CEO reveals 2030 growth plan as company faces up to $18 billion revenue hit from generics | CNBC
CNBC USA Health December 06, 2022
Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.Dado Ruvic Reuters has rejected allegations made by rival that its Covid-19 vaccine is a copy, accusing the Boston biotech company of... + más
Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate
Moderna is suing Pfizer over its coronavirus vaccine | The Verge
MarketWatch USA Business November 26, 2022
Rosenberg has been interviewed many times by Barron’s and has made some prescient calls. In late 2011, he compared (MSFT) favorably to (IBM), which had then drawn a big investment from (BRK.A). “Warren Buffett came pretty late to the IBM party,” he said. Microsoft is up... + más
Alphabet and Pfizer Stock Look Like Buys, Says This Longtime Market Maven | MarketWatch
CNBC USA Health November 04, 2022
In this articleA health worker administers a dose of Pfizer covid-19 vaccine to a man at the Sanford Civic Center. With the emergence of the Omicron covid-19 variant in numerous countries, including the United States, the US Centers for Disease Control (CDC) encouraged all... + más
Pfizer says omicron shots substantially boosted antibodies against BA.5 subvariant in early human data | CNBC
CDC recommends Covid omicron booster shots for kids as young as 5 years old | CNBC
CNBC USA Health November 02, 2022
Pfizer CEO Albert Bourla talks during a press conference with European Commission President after a visit to oversee the production of the Pfizer-BioNtech Covid-19 vaccine at the factory of US pharmaceutical company Pfizer, in Puurs, on April 23, 2021.John Thys AFP Getty Images... + más
Pfizer raises 2022 earnings guidance, beats third-quarter expectations | CNBC
Pfizer climbs on strong Q3 results, raised outlook | MarketWatch
About iurex | Privacy Policy | Disclaimer |